Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Chronic Intermittent Electronic Cigarette Exposure Induces Cardiac Dysfunction and Atherosclerosis in Apolipoprotein E (ApoE) Knockout Mice.

Espinoza-Derout J, Hasan KM, Shao XM, Jordan MC, Sims C, Lee DL, Sinha S, Simmons Z, Mtume N, Liu Y, Roos KP, Sinha-Hikim AP, Friedman TC.

Am J Physiol Heart Circ Physiol. 2019 Jun 7. doi: 10.1152/ajpheart.00738.2018. [Epub ahead of print]

PMID:
31172811
2.

ULTRASOUND IN THE DIAGNOSIS AND MONITORING OF AMYOTROPHIC LATERAL SCLEROSIS: A REVIEW.

Hobson-Webb LD, Simmons Z.

Muscle Nerve. 2019 Aug;60(2):114-123. doi: 10.1002/mus.26487. Epub 2019 Apr 25. Review.

PMID:
30989697
3.

Evaluation of remote pulmonary function testing in motor neuron disease.

Geronimo A, Simmons Z.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):348-355. doi: 10.1080/21678421.2019.1587633. Epub 2019 Apr 7.

PMID:
30957547
4.

Vowel-Specific Intelligibility and Acoustic Patterns in Individuals With Dysarthria Secondary to Amyotrophic Lateral Sclerosis.

Lee J, Dickey E, Simmons Z.

J Speech Lang Hear Res. 2019 Jan 30;62(1):34-59. doi: 10.1044/2018_JSLHR-S-17-0357.

PMID:
30950759
5.

Guidelines for authors: A view from the editor's desk.

Simmons Z.

Muscle Nerve. 2019 Feb;59(2):147-148. doi: 10.1002/mus.26399. Epub 2019 Jan 6. No abstract available.

PMID:
30549059
6.

Ethical Considerations in Neurogenetic Testing.

Su XW, Simmons Z.

Semin Neurol. 2018 Oct;38(5):505-514. doi: 10.1055/s-0038-1667382. Epub 2018 Oct 15. Review.

PMID:
30321888
7.

DdcA antagonizes a bacterial DNA damage checkpoint.

Burby PE, Simmons ZW, Simmons LA.

Mol Microbiol. 2019 Jan;111(1):237-253. doi: 10.1111/mmi.14151. Epub 2018 Nov 15.

PMID:
30315724
8.

Telemedicine to innovate amyotrophic lateral sclerosis multidisciplinary care: The time has come.

Paganoni S, Simmons Z.

Muscle Nerve. 2019 Jan;59(1):3-5. doi: 10.1002/mus.26311. Epub 2018 Dec 18. No abstract available.

PMID:
30066337
9.

Amyotrophic lateral sclerosis-specific quality of life-short form (ALSSQOL-SF): A brief, reliable, and valid version of the ALSSQOL-R.

Felgoise SH, Feinberg R, Stephens HE, Barkhaus P, Boylan K, Caress J, Clawson LL, Elman L, Goutman SA, Mccluskey L, Russell J, Tiryaki E, Weiss M, Simmons Z.

Muscle Nerve. 2018 Nov;58(5):646-654. doi: 10.1002/mus.26203. Epub 2018 Oct 19.

PMID:
30028537
10.

Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism.

Conlon EG, Fagegaltier D, Agius P, Davis-Porada J, Gregory J, Hubbard I, Kang K, Kim D; New York Genome Center ALS Consortium, Phatnani H, Kwan J, Sareen D, Broach JR, Simmons Z, Arcila-Londono X, Lee EB, Van Deerlin VM, Shneider NA, Fraenkel E, Ostrow LW, Baas F, Zaitlen N, Berry JD, Malaspina A, Fratta P, Cox GA, Thompson LM, Finkbeiner S, Dardiotis E, Miller TM, Chandran S, Pal S, Hornstein E, MacGowan DJ, Heiman-Patterson T, Hammell MG, Patsopoulos NA, Dubnau J, Nath A, Phatnani H, Shneider NA, Manley JL.

Elife. 2018 Jul 13;7. pii: e37754. doi: 10.7554/eLife.37754.

11.

Discovery of a dual protease mechanism that promotes DNA damage checkpoint recovery.

Burby PE, Simmons ZW, Schroeder JW, Simmons LA.

PLoS Genet. 2018 Jul 6;14(7):e1007512. doi: 10.1371/journal.pgen.1007512. eCollection 2018 Jul.

12.

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium, Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation for ALS Care (GTAC) Consortium, Moreno CAM, Kamalakaran S, Goldstein DB; ALS Sequencing Consortium, Gitler AD, Harris T, Myers RM; NYGC ALS Consortium, Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation, Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN Consortium, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C; French ALS Consortium, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC, Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de Belleroche J, Baas F, Ten Asbroek ALMA, Muñoz-Blanco JL, Hernandez DG, Ding J, Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S, Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T, Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M, McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R, Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Pérez J, García-Redondo A, Al-Chalabi A; Project MinE ALS Sequencing Consortium, Rogaeva E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Cooper-Knock J, Brice A, Goutman SA, Feldman EL, Gibson SB, Taroni F, Ratti A, Gellera C, Van Damme P, Robberecht W, Fratta P, Sabatelli M, Lunetta C, Ludolph AC, Andersen PM, Weishaupt JH, Camu W, Trojanowski JQ, Van Deerlin VM, Brown RH Jr, van den Berg LH, Veldink JH, Harms MB, Glass JD, Stone DJ, Tienari P, Silani V, Chiò A, Shaw CE, Traynor BJ, Landers JE.

Neuron. 2018 Mar 21;97(6):1268-1283.e6. doi: 10.1016/j.neuron.2018.02.027.

13.

Lawful physician-hastened death: AAN position statement.

Russell JA, Epstein LG, Bonnie RJ, Conwit R, Graf WD, Kirschen M, Kurek JA, Larriviere DG, Pascuzzi RM, Rizzo M, Sattin JA, Simmons Z, Taylor L, Tsou A, Williams MA; Ethics, Law, and Humanities Committee (a joint committee of the AAN, ANA, and CNS); Ethics, Law and Humanities Committee, a joint committee of the AAN, ANA and CNS.

Neurology. 2018 Feb 27;90(9):420-422. doi: 10.1212/WNL.0000000000005012. No abstract available.

14.

Discussing edaravone with the ALS patient: an ethical framework from a U.S. perspective.

Yeo CJJ, Simmons Z.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):167-172. doi: 10.1080/21678421.2018.1425455. Epub 2018 Jan 15.

PMID:
29334251
15.

Goodbye to neuromuscular images.

Simmons Z.

Muscle Nerve. 2018 Feb;57(2):167. doi: 10.1002/mus.26008. No abstract available.

PMID:
29330896
16.

Hydration measured by doubly labeled water in ALS and its effects on survival.

Scagnelli CN, Howard DB, Bromberg MB, Kasarskis EJ, Matthews DE, Mitsumoto HM, Simmons Z, Tandan R; ALS Nutrition-NIPPV Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):220-231. doi: 10.1080/21678421.2017.1413117. Epub 2017 Dec 15.

PMID:
29243507
17.

Articulatory Kinematic Characteristics Across the Dysarthria Severity Spectrum in Individuals With Amyotrophic Lateral Sclerosis.

Lee J, Bell M, Simmons Z.

Am J Speech Lang Pathol. 2018 Feb 6;27(1):258-269. doi: 10.1044/2017_AJSLP-16-0230.

PMID:
29209698
18.

Amyotrophic lateral sclerosis.

Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH.

Nat Rev Dis Primers. 2017 Oct 20;3:17085. doi: 10.1038/nrdp.2017.85.

PMID:
29052611
19.

Amyotrophic lateral sclerosis.

Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH.

Nat Rev Dis Primers. 2017 Oct 5;3:17071. doi: 10.1038/nrdp.2017.71. Review. Erratum in: Nat Rev Dis Primers. 2017 Oct 20;3:17085.

20.

Right-to-Try Investigational Therapies for Incurable Disorders.

Simmons Z.

Continuum (Minneap Minn). 2017 Oct;23(5, Peripheral Nerve and Motor Neuron Disorders):1451-1457. doi: 10.1212/CON.0000000000000515. Review.

PMID:
28968371
21.

Microscope objective based 4π spectroscopic tissue scattering goniometry.

Simmons ZJ, Rogers JD.

Biomed Opt Express. 2017 Jul 25;8(8):3828-3841. doi: 10.1364/BOE.8.003828. eCollection 2017 Aug 1.

22.

Expansion of C9ORF72 in amyotrophic lateral sclerosis correlates with brain-computer interface performance.

Geronimo A, Sheldon KE, Broach JR, Simmons Z, Schiff SJ.

Sci Rep. 2017 Aug 21;7(1):8875. doi: 10.1038/s41598-017-08857-3.

23.

Symptom management in amyotrophic lateral sclerosis: We can do better.

Goutman SA, Simmons Z.

Muscle Nerve. 2018 Jan;57(1):1-3. doi: 10.1002/mus.25740. Epub 2017 Aug 30. No abstract available.

24.

Incorporation of telehealth into a multidisciplinary ALS Clinic: feasibility and acceptability.

Geronimo A, Wright C, Morris A, Walsh S, Snyder B, Simmons Z.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):555-561. doi: 10.1080/21678421.2017.1338298. Epub 2017 Jul 5.

PMID:
28678542
25.

Advance care planning for patients with amyotrophic lateral sclerosis.

Levi BH, Simmons Z, Hanna C, Brothers A, Lehman E, Farace E, Bain M, Stewart R, Green MJ.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Aug;18(5-6):388-396. doi: 10.1080/21678421.2017.1285317. Epub 2017 Mar 5.

26.

Neuromuscular images: A picture can be worth more than a thousand words.

Simmons Z.

Muscle Nerve. 2017 Jul;56(1):1. doi: 10.1002/mus.25670. Epub 2017 Apr 26. No abstract available.

PMID:
28437832
27.

Article submission: The scope of muscle & nerve.

Simmons Z.

Muscle Nerve. 2017 May;55(5):615-616. doi: 10.1002/mus.25623. Epub 2017 Mar 21. No abstract available.

PMID:
28213938
28.

Ovarian hormone fluctuations predict within-cycle shifts in women's food intake.

Roney JR, Simmons ZL.

Horm Behav. 2017 Apr;90:8-14. doi: 10.1016/j.yhbeh.2017.01.009. Epub 2017 Feb 20.

PMID:
28202355
29.

Vitamin D induces myogenic differentiation in skeletal muscle derived stem cells.

Braga M, Simmons Z, Norris KC, Ferrini MG, Artaza JN.

Endocr Connect. 2017 Apr;6(3):139-150. doi: 10.1530/EC-17-0008. Epub 2017 Feb 7.

30.

Fixed dynamometry is more sensitive than vital capacity or ALS rating scale.

Andres PL, Allred MP, Stephens HE, Proffitt Bunnell M, Siener C, Macklin EA, Haines T, English RA, Fetterman KA, Kasarskis EJ, Florence J, Simmons Z, Cudkowicz ME.

Muscle Nerve. 2017 Oct;56(4):710-715. doi: 10.1002/mus.25586. Epub 2017 Mar 21.

PMID:
28120413
31.

So many submissions…so little space.

Simmons Z.

Muscle Nerve. 2017 Mar;55(3):299-300. doi: 10.1002/mus.25568. No abstract available.

PMID:
28066894
32.

Genetic Testing of Presymptomatic Individuals at Risk for Progressive Myopathy.

Simmons Z.

Continuum (Minneap Minn). 2016 Dec;22(6, Muscle and Neuromuscular Junction Disorders):2006-2011. Review.

PMID:
27922504
33.

The relationship between oestrogen and executive functioning in ALS females with emerging Frontotemporal Lobar Degeneration (FTLD) supports a neuroendocrine model of FTLD attenuation.

Flaherty C, Kraft J, Brothers A, Harrison M, Legro RS, Manni A, Yang C, Simmons Z; VALUES Consortium.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):74-85. doi: 10.1080/21678421.2016.1249487. Epub 2016 Nov 28.

PMID:
27892698
34.

A new editor: Changes in Muscle & Nerve.

Simmons Z.

Muscle Nerve. 2017 Jan;55(1):1-2. doi: 10.1002/mus.25456. Epub 2016 Nov 8. No abstract available.

PMID:
27787916
35.
36.

Ethical issues in the evaluation of adults with suspected genetic neuromuscular disorders.

Su X, Kang PB, Russell JA, Simmons Z.

Muscle Nerve. 2016 Dec;54(6):997-1006. doi: 10.1002/mus.25400. Epub 2016 Oct 1. Review.

PMID:
27615030
37.

Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.

van der Ploeg A, Carlier PG, Carlier RY, Kissel JT, Schoser B, Wenninger S, Pestronk A, Barohn RJ, Dimachkie MM, Goker-Alpan O, Mozaffar T, Pena LD, Simmons Z, Straub V, Guglieri M, Young P, Boentert M, Baudin PY, Wens S, Shafi R, Bjartmar C, Thurberg BL.

Mol Genet Metab. 2016 Sep;119(1-2):115-23. doi: 10.1016/j.ymgme.2016.05.013. Epub 2016 May 19.

38.

Acoustic and tongue kinematic vowel space in speakers with and without dysarthria.

Lee J, Littlejohn MA, Simmons Z.

Int J Speech Lang Pathol. 2017 Apr;19(2):195-204. doi: 10.1080/17549507.2016.1193899. Epub 2016 Jun 23.

PMID:
27336197
39.

Verbal communication impacts quality of life in patients with amyotrophic lateral sclerosis.

Felgoise SH, Zaccheo V, Duff J, Simmons Z.

Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):179-83. doi: 10.3109/21678421.2015.1125499. Epub 2015 Dec 21.

PMID:
27094742
40.

Within-cycle fluctuations in progesterone negatively predict changes in both in-pair and extra-pair desire among partnered women.

Roney JR, Simmons ZL.

Horm Behav. 2016 May;81:45-52. doi: 10.1016/j.yhbeh.2016.03.008. Epub 2016 Apr 2.

PMID:
27049465
41.

Reflections: neurology and the humanities. The Theory of Everything The extraordinary and the ordinary.

Simmons Z.

Neurology. 2015 Dec 8;85(23):2079-80. No abstract available.

PMID:
26985471
42.

A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.

Weiss MD, Macklin EA, Simmons Z, Knox AS, Greenblatt DJ, Atassi N, Graves M, Parziale N, Salameh JS, Quinn C, Brown RH Jr, Distad JB, Trivedi J, Shefner JM, Barohn RJ, Pestronk A, Swenson A, Cudkowicz ME; Mexiletine ALS Study Group.

Neurology. 2016 Apr 19;86(16):1474-81. doi: 10.1212/WNL.0000000000002507. Epub 2016 Feb 24.

43.

Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional Population.

Fournier CN, Murphy A, Loci L, Mitsumoto H, Lomen-Hoerth C, Kisanuki Y, Simmons Z, Maragakis NJ, McVey AL, Al-Lahham T, Heiman-Patterson TD, Andrews J, McDonnell E, Cudkowicz M, Atassi N.

J Clin Neuromuscul Dis. 2016 Mar;17(3):99-105. doi: 10.1097/CND.0000000000000102.

44.

The role of mental health and self-efficacy in the pain experience of patients with amyotrophic lateral sclerosis.

Stephens HE, Lehman E, Raheja D, Yang C, Walsh S, Simmons Z.

Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):206-12. doi: 10.3109/21678421.2015.1131832. Epub 2016 Feb 15.

PMID:
26878392
45.

Performance predictors of brain-computer interfaces in patients with amyotrophic lateral sclerosis.

Geronimo A, Simmons Z, Schiff SJ.

J Neural Eng. 2016 Apr;13(2):026002. doi: 10.1088/1741-2560/13/2/026002. Epub 2016 Jan 29.

PMID:
26824590
46.

Patient-reported problematic symptoms in an ALS treatment trial.

Raheja D, Stephens HE, Lehman E, Walsh S, Yang C, Simmons Z.

Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):198-205. doi: 10.3109/21678421.2015.1131831. Epub 2016 Jan 29.

47.

Statins accelerate disease progression and shorten survival in SOD1(G93A) mice.

Su XW, Nandar W, Neely EB, Simmons Z, Connor JR.

Muscle Nerve. 2016 Aug;54(2):284-91. doi: 10.1002/mus.25048. Epub 2016 May 19.

48.

The role of physical formidability in human social status allocation.

Lukaszewski AW, Simmons ZL, Anderson C, Roney JR.

J Pers Soc Psychol. 2016 Mar;110(3):385-406. doi: 10.1037/pspi0000042. Epub 2015 Dec 14.

PMID:
26653896
49.

Muscle & nerve joins the "App World".

Simmons Z, Raheja D.

Muscle Nerve. 2016 Jan;53(1):1-2. doi: 10.1002/mus.24973. Epub 2015 Nov 26. No abstract available.

PMID:
26565563
50.

Pain in amyotrophic lateral sclerosis: Patient and physician perspectives and practices.

Stephens HE, Lehman E, Raheja D, Yang C, Walsh S, Mcarthur DB, Simmons Z.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):21-9. doi: 10.3109/21678421.2015.1074701. Epub 2015 Oct 29.

PMID:
26513301

Supplemental Content

Loading ...
Support Center